Author

Abhishek Kumar

Amity University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Microbiology· 2 Bioinformatics· 1 Cell Biology· 1 Developmental Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Research Focus:cell type annotation· 3 Research Focus:differential expression· 3 Organism:human· 3 Research Focus:drug response / drug discovery· 2 Research Focus:gene regulatory network inference· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

Amit Kumar Singh· 2 shared Hridayesh PrakashiD· 2 shared Lalit Kumar SinghiD· 2 shared Niharika Sharma· 2 shared Vijay HaddaiD· 2 shared Abhilash JayarajiD· 1 shared Abigail J Dennis· 1 shared Abul Faiz· 1 shared

Activity by Year

2023-2026 · peak 5/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Amit Kumar Singh

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

HIV-1 Integrase C-terminal Domain Mutations Regulate ALLINI Sensitivity

Abhishek Kumar, Tung Dinh, Christian Shema Mugisha, Anthony Twumasi Boateng, Qianzi Zhou, Mamuka Kvaratskhelia, Sebla B. Kutluay

The paper shows that HIV-1 integrase C-terminal domain mutations affect sensitivity to ALLINIs by altering gRNA binding, despite being distant from the drug binding site.

bioRxiv · Oct 24, 2026 · PreprintMicrobiology

Sphingosine-1-Phosphate Restrains Foamy Macrophage Formation and Modulates Inflammation in Multidrug-Resistant Tuberculosis

Abhishek Kumar, Niharika Sharma, Lalit Kumar Singh, Vijay Hadda, Amit Kumar Singh, Hridayesh Prakash

This study investigates the role of sphingosine-1-phosphate (S1P) in modulating foamy macrophage formation and inflammation in multidrug-resistant tuberculosis (MDR-TB).

bioRxiv · Oct 20, 2026 · PreprintImmunology

A zebrafish ribosomopathy links Ddx49-dependent ribosome biogenesis to differential failure of population expansion among pigment cell lineages

Yipeng Liang, Kinga Malezyna, Abigail J Dennis, Abhishek Kumar, Braedan M. McCluskey, Diane S. Sepich, Lilianna Solnica‐Krezel, Arunkumar Dhayalan, Ahmad Jomaa, Larissa B. Patterson, David M. Parichy

This study identifies a zebrafish mutation in ddx49 causing differential cell-type vulnerability in pigment cells due to impaired ribosome biogenesis.

bioRxiv · Oct 15, 2026 · PreprintDevelopmental Biology

L-Serine and Palmitoyl CoA control Mycobacterial infection by tweaking protective immune response: A potential host directed therapy for tuberculosis

Niharika Sharma, Rahul Sharma, Abhishek Kumar, Lalit Kumar Singh, Anjaneya Ayanur, Vijay Hadda, Amit Kumar Singh, Hridayesh Prakash

This study investigates the role of L-Serine and palmitoyl CoA in enhancing the immune response against Mycobacterium tuberculosis, showing improved bacterial clearance and tissue recovery in murine models.

bioRxiv · Sep 3, 2026 · PreprintMicrobiology

ACTIVATED CASO₄-INDUCED VACUOLATION AS A QUANTITATIVE PLATFORM FOR PHAGOCYTOSIS-DRIVEN DRUG SCREENING

Vishakha Goswami, Abul Faiz, Gaurav Dutt, Abhishek Kumar, Saima Bashir, Arushi Gupta, Snehasish Das, Alpana Joshi, Subrata Kumar Das

This paper introduces a method using thermally activated calcium sulfate (ACS) to induce vacuolization in mammalian cells, enabling a scalable platform for drug screening related to phagocytosis and lysosomal function.

bioRxiv · Mar 13, 2026 · PreprintCell Biology

AI-Enhanced Adaptive Virtual Screening Platform Enabling Exploration of 69 Billion Molecules Discovers Structurally Validated FSP1 Inhibitors

Domiziana Cecchini, AkshatKumar Nigam, Ming Tang, Joana Reis, Matt Koop, Andrea Gottinger, Callum Robert Nicoll, Yao Wang, Abhilash Jayaraj, Suleyman Selim Cinaroglu, Ricarda Törner, Yehor S. Malets, Minko Gehev, Krishna M. Padmanabha Das, Kelly Churion, , Christoph Gorgulla

AdaptiveFlow enables large-scale virtual screening of 69 billion molecules to discover validated FSP1 inhibitors, improving efficiency and scalability in drug discovery.

bioRxiv · Apr 25, 2023 · PreprintBioinformatics